The ‘why’ behind our ridiculously high-quality cannabis products

Silver State Trading came about thanks to one simple question: “Have you tried medical marijuana?”

That question was posed to our Founder and CEO John Sutton one Friday evening in 2012 by a co-worker, who knew of his son’s very rare and very painful genetic disorder. He knew that after years of seeking treatment all over the world, John’s teenage son had been given a death sentence along with advice from medical professionals to load up on opioids to keep him comfortable.

The bold co-worker proceeded to give John a quarter ounce bag of marijuana and a handshake. Overnight, John and his wife decided it was worth a shot. The next morning, they found a YouTube video on how to make a pipe from a soda can, and let their son smoke.

Within five minutes, John’s son’s crippling pain level went from a nine to a three, and he was able to go down the stairs for the first time in a long while.

Cannabis was an absolute game changer.

Thirty days later, John quit his high-level position at a technology company and founded Silver State Trading.

“Silver State Trading is a proprietary blend of professionalism and passion. Tremendous care is infused into everything we do.” —John Sutton, Founder & CEO

The belief, the passion moving forward

Obviously, a lot has happened in the cannabis industry since 2012 when Silver State Trading was born—including the realization of the medical marijuana market followed by the recreational market in a handful of states. But no matter how big we get or how widespread our medical and recreational products become, our success will always be because:

  • we’re extremely passionate about cannabis
  • we believe in its goodness
  • we are professional to the core
  • we adhere to the highest standards, not minimum standards
  • we recognize the importance of quality AND value

We believe this is the only way to truly earn customer loyalty.

Meet our team.

John Sutton

Founder, Board Member, CEO

John is Silver State Trading’s beacon of light. He is primarily responsible for guiding our strategic direction, aligning the entire team with that vision, and balancing resources to remain a successful, dynamic company. He makes sure that strategic partners, customers and new hires alike understand our brand, company culture, belief system, and our overarching commitment to quality. John manages expectations and deliverables for all external stakeholders, and he also oversees compliance. He doesn’t sleep much.

Prior to starting Silver State Trading, John spent more than two decades as a consultant in market positioning, sales messaging and team alignment. His clients have included Fortune 1000 companies including SAP, Chevron, Google and Schlumberger.

John and his family live in northern Nevada. He attended both the University of Southern Oregon and the University of Oregon, graduating with a B.A. in Political Science with a primary focus on Business Law.

Dr. Kenton Crowley, Pharm. D., FAARFM

Director Of Research & Product Development

At SST Dr. Crowley is the Director of Research and Development, overseeing the production of Trokie™ products and future patents. Dr. Crowley is the founder and creator of Trokie™, holding the licensed IP technology. After Dr. Crowley developed and patented these two U.S. patents for the treatment of neuropathic pain and a method and process patent-pending for cannabis buccal delivery, he joined with SST to bring Nevadans the Trokie™ lozenges. A highly trained pharmaceutical executive and consultant, Dr. Crowley has over 30 years of experience in the pharmaceutical industry and clinical medicine. He obtained his Doctor of Pharmacy from the University of California, San Francisco; completed an ASHP Accredited Residency with Kaiser Permanente. He is an Advanced Fellow and Diplomat of the American Academy of Anti-Aging Medicine. An inventor, drug developer, professor, author, clinician and entrepreneur, Dr. Crowley continues to offer cutting-edge approaches to solving the problems faced by established as well as emerging new business models in medicine and the pharmaceutical industry.